[Helicobacter pylori and gastroduodenal pathology in patient with chronic renal insufficiency undergoing dialysis]

Nefrologia. 2002;22(4):318-24.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Anemia / etiology
  • Anemia / metabolism
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Ulcer Agents / therapeutic use
  • Comorbidity
  • Disease Susceptibility
  • Drug Therapy, Combination
  • Duodenal Diseases / complications*
  • Duodenal Diseases / epidemiology
  • Duodenal Diseases / microbiology
  • Duodenal Ulcer / complications
  • Duodenal Ulcer / epidemiology
  • Duodenal Ulcer / microbiology
  • Enzyme Inhibitors / therapeutic use
  • Gastrins / metabolism
  • Helicobacter Infections / complications*
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / epidemiology
  • Helicobacter Infections / microbiology
  • Helicobacter Infections / physiopathology
  • Helicobacter pylori*
  • Humans
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / epidemiology
  • Kidney Failure, Chronic / therapy
  • Malabsorption Syndromes / etiology
  • Prevalence
  • Proton Pump Inhibitors
  • Renal Dialysis* / adverse effects
  • Stomach Diseases / complications*
  • Stomach Diseases / epidemiology
  • Stomach Diseases / microbiology
  • Stomach Ulcer / complications
  • Stomach Ulcer / epidemiology
  • Stomach Ulcer / microbiology
  • Urea / metabolism

Substances

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Enzyme Inhibitors
  • Gastrins
  • Proton Pump Inhibitors
  • Urea